Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Mayeur ME"'
Autor:
Cabirol MJ; Institut de Neurosciences Cognitives et Intégratives d'Aquitaine, CNRS, Université de Bordeaux, Bordeaux, France., Cardoit L; Institut de Neurosciences Cognitives et Intégratives d'Aquitaine, CNRS, Université de Bordeaux, Bordeaux, France., Courtand G; Institut de Neurosciences Cognitives et Intégratives d'Aquitaine, CNRS, Université de Bordeaux, Bordeaux, France., Mayeur ME; MeLis INSERM U1314-CNRS UMR 5284, Faculté Rockefeller, Lyon, France., Simmers J; Institut de Neurosciences Cognitives et Intégratives d'Aquitaine, CNRS, Université de Bordeaux, Bordeaux, France., Pascual O; MeLis INSERM U1314-CNRS UMR 5284, Faculté Rockefeller, Lyon, France., Thoby-Brisson M; Institut de Neurosciences Cognitives et Intégratives d'Aquitaine, CNRS, Université de Bordeaux, Bordeaux, France.
Publikováno v:
ELife [Elife] 2022 Nov 02; Vol. 11. Date of Electronic Publication: 2022 Nov 02.
Autor:
Fels E; Synaptopathies and Auto-antibodies (SynatAc) Team, Institut NeuroMyoGène, MeLis-CNRS UMR 5284-INSERM U1314, Universités de Lyon, Université Claude Bernard Lyon 1, Lyon, France.; Université Claude Bernard Lyon 1, Universités de Lyon, Lyon, France.; MeLis-CNRS UMR 5284-INSERM U1314, Lyon, France., Mayeur ME; Synaptopathies and Auto-antibodies (SynatAc) Team, Institut NeuroMyoGène, MeLis-CNRS UMR 5284-INSERM U1314, Universités de Lyon, Université Claude Bernard Lyon 1, Lyon, France.; Université Claude Bernard Lyon 1, Universités de Lyon, Lyon, France.; MeLis-CNRS UMR 5284-INSERM U1314, Lyon, France., Wayere E; Synaptopathies and Auto-antibodies (SynatAc) Team, Institut NeuroMyoGène, MeLis-CNRS UMR 5284-INSERM U1314, Universités de Lyon, Université Claude Bernard Lyon 1, Lyon, France.; Université Claude Bernard Lyon 1, Universités de Lyon, Lyon, France.; MeLis-CNRS UMR 5284-INSERM U1314, Lyon, France., Vincent C; Synaptopathies and Auto-antibodies (SynatAc) Team, Institut NeuroMyoGène, MeLis-CNRS UMR 5284-INSERM U1314, Universités de Lyon, Université Claude Bernard Lyon 1, Lyon, France.; Université Claude Bernard Lyon 1, Universités de Lyon, Lyon, France.; MeLis-CNRS UMR 5284-INSERM U1314, Lyon, France.; French Reference Center on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis, Hospices Civils de Lyon, Hôpital Neurologique, Bron Cedex, France., Malleval C; Synaptopathies and Auto-antibodies (SynatAc) Team, Institut NeuroMyoGène, MeLis-CNRS UMR 5284-INSERM U1314, Universités de Lyon, Université Claude Bernard Lyon 1, Lyon, France.; Université Claude Bernard Lyon 1, Universités de Lyon, Lyon, France.; MeLis-CNRS UMR 5284-INSERM U1314, Lyon, France., Honnorat J; Synaptopathies and Auto-antibodies (SynatAc) Team, Institut NeuroMyoGène, MeLis-CNRS UMR 5284-INSERM U1314, Universités de Lyon, Université Claude Bernard Lyon 1, Lyon, France.; Université Claude Bernard Lyon 1, Universités de Lyon, Lyon, France.; MeLis-CNRS UMR 5284-INSERM U1314, Lyon, France.; French Reference Center on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis, Hospices Civils de Lyon, Hôpital Neurologique, Bron Cedex, France., Pascual O; Synaptopathies and Auto-antibodies (SynatAc) Team, Institut NeuroMyoGène, MeLis-CNRS UMR 5284-INSERM U1314, Universités de Lyon, Université Claude Bernard Lyon 1, Lyon, France.; Université Claude Bernard Lyon 1, Universités de Lyon, Lyon, France.; MeLis-CNRS UMR 5284-INSERM U1314, Lyon, France.
Publikováno v:
PloS one [PLoS One] 2022 Aug 19; Vol. 17 (8), pp. e0272277. Date of Electronic Publication: 2022 Aug 19 (Print Publication: 2022).
Autor:
Zakaria M; INSERM-University Paris-Sud/Paris-Saclay; Diseases and Hormones of the Nervous System, U1195, 80 rue du Général Leclerc, F-94276, Le Kremlin-Bicêtre, France., Ferent J; IRCM, Molecular Biology of Neural Development, 110 Pine Avenue West, Montreal, Quebec H2W 1R7, Canada; Department of Medicine, University of Montreal, Montreal, Quebec, Canada; McGill University, Montreal, Quebec, Canada., Hristovska I; Institut NeuroMyoGène CNRS UMR 5310-INSERM U1217-Université Claude Bernard Lyon 1, Faculté de Médecine et de Pharmacie 69008 Lyon, France., Laouarem Y; INSERM-University Paris-Sud/Paris-Saclay; Diseases and Hormones of the Nervous System, U1195, 80 rue du Général Leclerc, F-94276, Le Kremlin-Bicêtre, France., Zahaf A; INSERM-University Paris-Sud/Paris-Saclay; Diseases and Hormones of the Nervous System, U1195, 80 rue du Général Leclerc, F-94276, Le Kremlin-Bicêtre, France., Kassoussi A; INSERM-University Paris-Sud/Paris-Saclay; Diseases and Hormones of the Nervous System, U1195, 80 rue du Général Leclerc, F-94276, Le Kremlin-Bicêtre, France., Mayeur ME; Institut NeuroMyoGène CNRS UMR 5310-INSERM U1217-Université Claude Bernard Lyon 1, Faculté de Médecine et de Pharmacie 69008 Lyon, France., Pascual O; Institut NeuroMyoGène CNRS UMR 5310-INSERM U1217-Université Claude Bernard Lyon 1, Faculté de Médecine et de Pharmacie 69008 Lyon, France., Charron F; IRCM, Molecular Biology of Neural Development, 110 Pine Avenue West, Montreal, Quebec H2W 1R7, Canada; Department of Medicine, University of Montreal, Montreal, Quebec, Canada; McGill University, Montreal, Quebec, Canada., Traiffort E; INSERM-University Paris-Sud/Paris-Saclay; Diseases and Hormones of the Nervous System, U1195, 80 rue du Général Leclerc, F-94276, Le Kremlin-Bicêtre, France elisabeth.traiffort@inserm.fr.
Publikováno v:
Development (Cambridge, England) [Development] 2019 May 02; Vol. 146 (9). Date of Electronic Publication: 2019 May 02.
Autor:
Chefdeville A; Institut NeuroMyogène, Equipe Synaptopathies et Autoanticorps (SynatAc), INSERM U1217/UMR CRS 5310, Lyon, France.; University of Lyon, Université Claude Bernard Lyon 1, Lyon, France., Treilleux I; Department of Biopathology, Centre Leon Berard, Lyon, France., Mayeur ME; Institut NeuroMyogène, Equipe Synaptopathies et Autoanticorps (SynatAc), INSERM U1217/UMR CRS 5310, Lyon, France., Couillault C; University of Lyon, Université Claude Bernard Lyon 1, Lyon, France.; INSERM 1052, CNRS 5286, Centre Leon Berard, Centre de Recherche en Cancérologie de Lyon, Lyon, France., Picard G; French Reference Center on Paraneoplastic Neurological Syndrome, Hospices Civils de Lyon, Lyon, France., Bost C; Institut NeuroMyogène, Equipe Synaptopathies et Autoanticorps (SynatAc), INSERM U1217/UMR CRS 5310, Lyon, France.; University of Lyon, Université Claude Bernard Lyon 1, Lyon, France.; French Reference Center on Paraneoplastic Neurological Syndrome, Hospices Civils de Lyon, Lyon, France., Mokhtari K; Raymond Escourolle Neuropathology Laboratory, Groupement Pitie-Salpetriere, AP-HP, Paris, France., Vasiljevic A; University of Lyon, Université Claude Bernard Lyon 1, Lyon, France.; Department of Pathology, Groupement hospitalier Est, Hospices Civils de Lyon, Lyon, France., Meyronet D; University of Lyon, Université Claude Bernard Lyon 1, Lyon, France.; Department of Pathology, Groupement hospitalier Est, Hospices Civils de Lyon, Lyon, France., Rogemond V; French Reference Center on Paraneoplastic Neurological Syndrome, Hospices Civils de Lyon, Lyon, France., Psimaras D; French Reference Center on Paraneoplastic Neurological Syndrome, Hospices Civils de Lyon, Lyon, France., Dubois B; INSERM 1052, CNRS 5286, Centre Leon Berard, Centre de Recherche en Cancérologie de Lyon, Lyon, France., Honnorat J; Institut NeuroMyogène, Equipe Synaptopathies et Autoanticorps (SynatAc), INSERM U1217/UMR CRS 5310, Lyon, France.; University of Lyon, Université Claude Bernard Lyon 1, Lyon, France.; French Reference Center on Paraneoplastic Neurological Syndrome, Hospices Civils de Lyon, Lyon, France.; Hôpital Neurologique Pierre Wertheimer, 59 Boulevard Pinel, 69677, Bron Cedex, France., Desestret V; Institut NeuroMyogène, Equipe Synaptopathies et Autoanticorps (SynatAc), INSERM U1217/UMR CRS 5310, Lyon, France. virginie.desestret@chu-lyon.fr.; University of Lyon, Université Claude Bernard Lyon 1, Lyon, France. virginie.desestret@chu-lyon.fr.; French Reference Center on Paraneoplastic Neurological Syndrome, Hospices Civils de Lyon, Lyon, France. virginie.desestret@chu-lyon.fr.; Hôpital Neurologique Pierre Wertheimer, 59 Boulevard Pinel, 69677, Bron Cedex, France. virginie.desestret@chu-lyon.fr.
Publikováno v:
Acta neuropathologica communications [Acta Neuropathol Commun] 2019 Mar 11; Vol. 7 (1), pp. 38. Date of Electronic Publication: 2019 Mar 11.
Autor:
Bost C; French Reference Center for Paraneoplastic Neurological Syndrome, Hospices Civils de Lyon, Hôpital Neurologique, 69677, Bron, France.; Institut NeuroMyoGene INSERM U1217/CNRS UMR 5310, Université de Lyon, Université Claude Bernard Lyon 1, 69372, Lyon, France.; University of Lyon, Université Claude Bernard Lyon 1, Lyon, 69372, Lyon, France., Chanson E; French Reference Center for Paraneoplastic Neurological Syndrome, Hospices Civils de Lyon, Hôpital Neurologique, 69677, Bron, France.; Institut NeuroMyoGene INSERM U1217/CNRS UMR 5310, Université de Lyon, Université Claude Bernard Lyon 1, 69372, Lyon, France.; University of Lyon, Université Claude Bernard Lyon 1, Lyon, 69372, Lyon, France., Picard G; French Reference Center for Paraneoplastic Neurological Syndrome, Hospices Civils de Lyon, Hôpital Neurologique, 69677, Bron, France., Meyronet D; University of Lyon, Université Claude Bernard Lyon 1, Lyon, 69372, Lyon, France.; INSERM 1052, CNRS 5286, Centre Leon Berard, Centre de Recherche en Cancérologie de Lyon, 69008, Lyon, France., Mayeur ME; Institut NeuroMyoGene INSERM U1217/CNRS UMR 5310, Université de Lyon, Université Claude Bernard Lyon 1, 69372, Lyon, France., Ducray F; French Reference Center for Paraneoplastic Neurological Syndrome, Hospices Civils de Lyon, Hôpital Neurologique, 69677, Bron, France.; Institut NeuroMyoGene INSERM U1217/CNRS UMR 5310, Université de Lyon, Université Claude Bernard Lyon 1, 69372, Lyon, France.; University of Lyon, Université Claude Bernard Lyon 1, Lyon, 69372, Lyon, France.; INSERM 1052, CNRS 5286, Centre Leon Berard, Centre de Recherche en Cancérologie de Lyon, 69008, Lyon, France., Rogemond V; French Reference Center for Paraneoplastic Neurological Syndrome, Hospices Civils de Lyon, Hôpital Neurologique, 69677, Bron, France.; Institut NeuroMyoGene INSERM U1217/CNRS UMR 5310, Université de Lyon, Université Claude Bernard Lyon 1, 69372, Lyon, France., Psimaras D; French Reference Center for Paraneoplastic Neurological Syndrome, Hospices Civils de Lyon, Hôpital Neurologique, 69677, Bron, France.; Groupe Hospitalier Pitié-Salpêtrière, Service de neurologie 2-Mazarin, AP-HP, 75013, Paris, France., Antoine JC; French Reference Center for Paraneoplastic Neurological Syndrome, Hospices Civils de Lyon, Hôpital Neurologique, 69677, Bron, France.; Institut NeuroMyoGene INSERM U1217/CNRS UMR 5310, Université de Lyon, Université Claude Bernard Lyon 1, 69372, Lyon, France.; Service de Neurologie, CHU de Saint-Etienne et Université de Lyon, 42023, Saint-Etienne, France., Delattre JY; French Reference Center for Paraneoplastic Neurological Syndrome, Hospices Civils de Lyon, Hôpital Neurologique, 69677, Bron, France.; Groupe Hospitalier Pitié-Salpêtrière, Service de neurologie 2-Mazarin, AP-HP, 75013, Paris, France.; Inserm, U 1127, CNRS, UMR 7225, ICM, Sorbonne Universités, UPMC Univ. Paris 06, UM 75 Paris, 75013, Paris, France., Desestret V; French Reference Center for Paraneoplastic Neurological Syndrome, Hospices Civils de Lyon, Hôpital Neurologique, 69677, Bron, France.; Institut NeuroMyoGene INSERM U1217/CNRS UMR 5310, Université de Lyon, Université Claude Bernard Lyon 1, 69372, Lyon, France.; University of Lyon, Université Claude Bernard Lyon 1, Lyon, 69372, Lyon, France., Honnorat J; French Reference Center for Paraneoplastic Neurological Syndrome, Hospices Civils de Lyon, Hôpital Neurologique, 69677, Bron, France. jerome.honnorat@chu-lyon.fr.; Institut NeuroMyoGene INSERM U1217/CNRS UMR 5310, Université de Lyon, Université Claude Bernard Lyon 1, 69372, Lyon, France. jerome.honnorat@chu-lyon.fr.; University of Lyon, Université Claude Bernard Lyon 1, Lyon, 69372, Lyon, France. jerome.honnorat@chu-lyon.fr.; Neuro-Oncologie, Hôpital Neurologique Pierre Wertheimer, 59 Boulevard Pinel, 69677, Bron Cedex, France. jerome.honnorat@chu-lyon.fr.
Publikováno v:
Journal of neurology [J Neurol] 2018 Oct; Vol. 265 (10), pp. 2190-2200. Date of Electronic Publication: 2018 Jul 12.
Autor:
Afanasiev V; From the Neurology Department (V.A., M.-L.B.), Saint-Antoine Hospital, Université Pierre et Marie Curie, Paris; Neuro-Oncology Department, Mazarin (W.B., D.P.), General, Visceral and Endocrine Surgery Department (R.D.), Physical Medicine and Rehabilitation Department (A.P.), Groupe Hospitalier Pitié-Salpétrière Université Pierre et Marie Curie, Paris; INSERM U1028 (M.-E.M., D.M., V.D.), CNRS UM5292, Neuro-oncology and Neuro-inflammation Team, Université Claude Bernard Lyon 1; and Pathology and Neuropathology Est Center (D.M.), Hospices Civils de Lyon, France., Brechemier ML; From the Neurology Department (V.A., M.-L.B.), Saint-Antoine Hospital, Université Pierre et Marie Curie, Paris; Neuro-Oncology Department, Mazarin (W.B., D.P.), General, Visceral and Endocrine Surgery Department (R.D.), Physical Medicine and Rehabilitation Department (A.P.), Groupe Hospitalier Pitié-Salpétrière Université Pierre et Marie Curie, Paris; INSERM U1028 (M.-E.M., D.M., V.D.), CNRS UM5292, Neuro-oncology and Neuro-inflammation Team, Université Claude Bernard Lyon 1; and Pathology and Neuropathology Est Center (D.M.), Hospices Civils de Lyon, France., Boisseau W; From the Neurology Department (V.A., M.-L.B.), Saint-Antoine Hospital, Université Pierre et Marie Curie, Paris; Neuro-Oncology Department, Mazarin (W.B., D.P.), General, Visceral and Endocrine Surgery Department (R.D.), Physical Medicine and Rehabilitation Department (A.P.), Groupe Hospitalier Pitié-Salpétrière Université Pierre et Marie Curie, Paris; INSERM U1028 (M.-E.M., D.M., V.D.), CNRS UM5292, Neuro-oncology and Neuro-inflammation Team, Université Claude Bernard Lyon 1; and Pathology and Neuropathology Est Center (D.M.), Hospices Civils de Lyon, France., Ducoudray R; From the Neurology Department (V.A., M.-L.B.), Saint-Antoine Hospital, Université Pierre et Marie Curie, Paris; Neuro-Oncology Department, Mazarin (W.B., D.P.), General, Visceral and Endocrine Surgery Department (R.D.), Physical Medicine and Rehabilitation Department (A.P.), Groupe Hospitalier Pitié-Salpétrière Université Pierre et Marie Curie, Paris; INSERM U1028 (M.-E.M., D.M., V.D.), CNRS UM5292, Neuro-oncology and Neuro-inflammation Team, Université Claude Bernard Lyon 1; and Pathology and Neuropathology Est Center (D.M.), Hospices Civils de Lyon, France., Mayeur ME; From the Neurology Department (V.A., M.-L.B.), Saint-Antoine Hospital, Université Pierre et Marie Curie, Paris; Neuro-Oncology Department, Mazarin (W.B., D.P.), General, Visceral and Endocrine Surgery Department (R.D.), Physical Medicine and Rehabilitation Department (A.P.), Groupe Hospitalier Pitié-Salpétrière Université Pierre et Marie Curie, Paris; INSERM U1028 (M.-E.M., D.M., V.D.), CNRS UM5292, Neuro-oncology and Neuro-inflammation Team, Université Claude Bernard Lyon 1; and Pathology and Neuropathology Est Center (D.M.), Hospices Civils de Lyon, France., Meyronet D; From the Neurology Department (V.A., M.-L.B.), Saint-Antoine Hospital, Université Pierre et Marie Curie, Paris; Neuro-Oncology Department, Mazarin (W.B., D.P.), General, Visceral and Endocrine Surgery Department (R.D.), Physical Medicine and Rehabilitation Department (A.P.), Groupe Hospitalier Pitié-Salpétrière Université Pierre et Marie Curie, Paris; INSERM U1028 (M.-E.M., D.M., V.D.), CNRS UM5292, Neuro-oncology and Neuro-inflammation Team, Université Claude Bernard Lyon 1; and Pathology and Neuropathology Est Center (D.M.), Hospices Civils de Lyon, France., Peskine A; From the Neurology Department (V.A., M.-L.B.), Saint-Antoine Hospital, Université Pierre et Marie Curie, Paris; Neuro-Oncology Department, Mazarin (W.B., D.P.), General, Visceral and Endocrine Surgery Department (R.D.), Physical Medicine and Rehabilitation Department (A.P.), Groupe Hospitalier Pitié-Salpétrière Université Pierre et Marie Curie, Paris; INSERM U1028 (M.-E.M., D.M., V.D.), CNRS UM5292, Neuro-oncology and Neuro-inflammation Team, Université Claude Bernard Lyon 1; and Pathology and Neuropathology Est Center (D.M.), Hospices Civils de Lyon, France., Desestret V; From the Neurology Department (V.A., M.-L.B.), Saint-Antoine Hospital, Université Pierre et Marie Curie, Paris; Neuro-Oncology Department, Mazarin (W.B., D.P.), General, Visceral and Endocrine Surgery Department (R.D.), Physical Medicine and Rehabilitation Department (A.P.), Groupe Hospitalier Pitié-Salpétrière Université Pierre et Marie Curie, Paris; INSERM U1028 (M.-E.M., D.M., V.D.), CNRS UM5292, Neuro-oncology and Neuro-inflammation Team, Université Claude Bernard Lyon 1; and Pathology and Neuropathology Est Center (D.M.), Hospices Civils de Lyon, France., Psimaras D; From the Neurology Department (V.A., M.-L.B.), Saint-Antoine Hospital, Université Pierre et Marie Curie, Paris; Neuro-Oncology Department, Mazarin (W.B., D.P.), General, Visceral and Endocrine Surgery Department (R.D.), Physical Medicine and Rehabilitation Department (A.P.), Groupe Hospitalier Pitié-Salpétrière Université Pierre et Marie Curie, Paris; INSERM U1028 (M.-E.M., D.M., V.D.), CNRS UM5292, Neuro-oncology and Neuro-inflammation Team, Université Claude Bernard Lyon 1; and Pathology and Neuropathology Est Center (D.M.), Hospices Civils de Lyon, France. dimitri.psimaras@aphp.fr.
Publikováno v:
Neurology [Neurology] 2016 Jul 05; Vol. 87 (1), pp. 112-3. Date of Electronic Publication: 2016 Jun 08.
Autor:
Moutal A; INSERM U1028, CNRS UM5292, Lyon Neuroscience Research Center, Neuro-oncology and Neuro-inflammation Team, University Claude Bernard Lyon 1, Lyon, France., Honnorat J; INSERM U1028, CNRS UM5292, Lyon Neuroscience Research Center, Neuro-oncology and Neuro-inflammation Team, University Claude Bernard Lyon 1, Lyon, France., Massoma P; INSERM U1028, CNRS UM5292, Lyon Neuroscience Research Center, Neuro-oncology and Neuro-inflammation Team, University Claude Bernard Lyon 1, Lyon, France., Désormeaux P; INSERM U1028, CNRS UM5292, Lyon Neuroscience Research Center, Neuro-oncology and Neuro-inflammation Team, University Claude Bernard Lyon 1, Lyon, France., Bertrand C; INSERM U1028, CNRS UM5292, Lyon Neuroscience Research Center, Neuro-oncology and Neuro-inflammation Team, University Claude Bernard Lyon 1, Lyon, France., Malleval C; INSERM U1028, CNRS UM5292, Lyon Neuroscience Research Center, Neuro-oncology and Neuro-inflammation Team, University Claude Bernard Lyon 1, Lyon, France., Watrin C; INSERM U1028, CNRS UM5292, Lyon Neuroscience Research Center, Neuro-oncology and Neuro-inflammation Team, University Claude Bernard Lyon 1, Lyon, France., Chounlamountri N; INSERM U1028, CNRS UM5292, Lyon Neuroscience Research Center, Neuro-oncology and Neuro-inflammation Team, University Claude Bernard Lyon 1, Lyon, France., Mayeur ME; INSERM U1028, CNRS UM5292, Lyon Neuroscience Research Center, Neuro-oncology and Neuro-inflammation Team, University Claude Bernard Lyon 1, Lyon, France., Besançon R; INSERM U1028, CNRS UM5292, Lyon Neuroscience Research Center, Neuro-oncology and Neuro-inflammation Team, University Claude Bernard Lyon 1, Lyon, France., Naudet N; INSERM U1028, CNRS UM5292, Lyon Neuroscience Research Center, Neuro-oncology and Neuro-inflammation Team, University Claude Bernard Lyon 1, Lyon, France., Magadoux L; INSERM U1028, CNRS UM5292, Lyon Neuroscience Research Center, Neuro-oncology and Neuro-inflammation Team, University Claude Bernard Lyon 1, Lyon, France., Khanna R; Department of Pharmacology and Neuroscience Graduate Interdisciplinary Program, College of Medicine, University of Arizona, Tucson, Arizona., Ducray F; INSERM U1028, CNRS UM5292, Lyon Neuroscience Research Center, Neuro-oncology and Neuro-inflammation Team, University Claude Bernard Lyon 1, Lyon, France. Hospices Civils de Lyon, Neuro-Oncology, Lyon, France., Meyronet D; INSERM U1028, CNRS UM5292, Lyon Neuroscience Research Center, Neuro-oncology and Neuro-inflammation Team, University Claude Bernard Lyon 1, Lyon, France. Hospices Civils de Lyon, Centre de Pathologie et de Neuropathologie Est, Lyon, France., Thomasset N; INSERM U1028, CNRS UM5292, Lyon Neuroscience Research Center, Neuro-oncology and Neuro-inflammation Team, University Claude Bernard Lyon 1, Lyon, France. nicole.thomasset@inserm.fr.
Publikováno v:
Cancer research [Cancer Res] 2015 Sep 01; Vol. 75 (17), pp. 3519-28. Date of Electronic Publication: 2015 Jun 29.